Revlimid (lenalidomide) Important Safety Information from Celgene as approved by theIrish Medicines Board

Notice type: 3rd Party Publications

Date: 26/06/2013

Problem Or Issue:
Important Safety Information communication from Celgene on important aspects in the clinical use of Revlimid (lenalidomide).

Important Safety Information - Revlimid (lenalidomide)

« Back